Growing community of inventors

Lebanon, NH, United States of America

Sabrina Ceeraz

Average Co-Inventor Count = 5.83

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 11

Sabrina CeerazRandolph J Noelle (6 patents)Sabrina CeerazElizabeth Nowak (6 patents)Sabrina CeerazIsabelle Lemercier (6 patents)Sabrina CeerazJanet Lines (6 patents)Sabrina CeerazLi Wang (3 patents)Sabrina CeerazMark R Spaller (3 patents)Sabrina CeerazJanet Lines (1 patent)Sabrina CeerazLi Wang (1 patent)Sabrina CeerazJanet Louise Lines (0 patent)Sabrina CeerazMark Spaller (1 patent)Sabrina CeerazJanet Louise Lines (1 patent)Sabrina CeerazSabrina Ceeraz (6 patents)Randolph J NoelleRandolph J Noelle (66 patents)Elizabeth NowakElizabeth Nowak (18 patents)Isabelle LemercierIsabelle Lemercier (8 patents)Janet LinesJanet Lines (6 patents)Li WangLi Wang (9 patents)Mark R SpallerMark R Spaller (8 patents)Janet LinesJanet Lines (2 patents)Li WangLi Wang (6 patents)Janet Louise LinesJanet Louise Lines (0 patent)Mark SpallerMark Spaller (1 patent)Janet Louise LinesJanet Louise Lines (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. King's College London (6 from 176 patents)

2. Dartmouth College (5 from 664 patents)

3. Darmouth College (1 from 7 patents)

4. Spaller, Mark (0 patent)

5. Mark Spaller (0 patent)


6 patents:

1. 12162928 - VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders

2. 12071473 - VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders

3. 12064463 - Vista antagonist and methods of use

4. 11752189 - Vista antagonist and methods of use

5. 10933115 - VISTA antagonist and methods of use

6. 10745467 - VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/30/2025
Loading…